JP2016512245A5 - マイボーム腺を標的とする組成物 - Google Patents
マイボーム腺を標的とする組成物 Download PDFInfo
- Publication number
- JP2016512245A5 JP2016512245A5 JP2016500204A JP2016500204A JP2016512245A5 JP 2016512245 A5 JP2016512245 A5 JP 2016512245A5 JP 2016500204 A JP2016500204 A JP 2016500204A JP 2016500204 A JP2016500204 A JP 2016500204A JP 2016512245 A5 JP2016512245 A5 JP 2016512245A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- quality
- meibum
- inflamed
- improving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims 30
- 210000004175 Meibomian Glands Anatomy 0.000 title claims 12
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 6
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims 5
- 241000124008 Mammalia Species 0.000 claims 3
- 229940012843 Omega-3 Fatty Acids Drugs 0.000 claims 3
- 210000001138 Tears Anatomy 0.000 claims 3
- 230000004064 dysfunction Effects 0.000 claims 3
- 239000006014 omega-3 oil Substances 0.000 claims 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N Docosahexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 2
- 150000003626 triacylglycerols Chemical class 0.000 claims 2
- 229960005135 Eicosapentaenoic Acid Drugs 0.000 claims 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N Eicosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims 1
- 206010065062 Meibomian gland dysfunction Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000003110 anti-inflammatory Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 230000002757 inflammatory Effects 0.000 claims 1
Claims (11)
- 炎症を起こしたか又は機能不全のマイボーム腺のマイバム組成物の質を改善するための組成物であって、前記組成物は、
1日量単位で有効な量のオメガ−3脂肪酸からなる活性成分を含み、前記オメガ−3脂肪酸は600mgを超える量でありかつトリグリセリドの形態を含んでなるエイコサペンタエン酸(EPA)を含み、
前記組成物は、治療されるマイボーム腺のマイバムの組成物中の抗炎症性のオメガ−3のレベルを増大させるとともに前記マイバムの組成物中の炎症性のオメガ−6のレベルを減少させるものである、組成物。 - 前記有効な量のオメガ−3脂肪酸は、2,000mg〜3,000mgの量を含んでなる、請求項1に記載の炎症を起こしたか又は機能不全のマイボーム腺のマイバム組成物の質を改善するための組成物。
- 前記EPAは再エステル化されたトリグリセリドの形態を含んでなる、請求項1に記載の炎症を起こしたか又は機能不全のマイボーム腺のマイバム組成物の質を改善するための組成物。
- 前記EPAは1,600mg〜2,500mgの量を含んでなる、請求項1に記載の炎症を起こしたか又は機能不全のマイボーム腺のマイバム組成物の質を改善するための組成物。
- 前記EPAは1,600mg〜1,800mgの量を含んでなる、請求項1に記載の炎症を起こしたか又は機能不全のマイボーム腺のマイバム組成物の質を改善するための組成物。
- 前記有効な量の前記オメガ−3脂肪酸は500mgを超える量のドコサヘキサエン酸(DHA)を含む、請求項1に記載の炎症を起こしたか又は機能不全のマイボーム腺のマイバム組成物の質を改善するための組成物。
- 前記DHAは500mg〜900mgの量を含んでなる、請求項6に記載の炎症を起こしたか又は機能不全のマイボーム腺のマイバム組成物の質を改善するための組成物。
- 前記有効な量のオメガ−3脂肪酸は前記量のEPA及び前記量のDHAを3:1の比で含んでなる、請求項6に記載の炎症を起こしたか又は機能不全のマイボーム腺のマイバム組成物の質を改善するための組成物。
- 前記組成物は哺乳動物の涙液の質を改善するものである、請求項1に記載の炎症を起こしたか又は機能不全のマイボーム腺のマイバム組成物の質を改善するための組成物。
- 前記組成物は哺乳動物の涙液層破壊時間を改善するものである、請求項1に記載の炎症を起こしたか又は機能不全のマイボーム腺のマイバム組成物の質を改善するための組成物。
- 前記組成物は哺乳動物の涙液浸透圧モル濃度を低減するものである、請求項1に記載の炎症を起こしたか又は機能不全のマイボーム腺のマイバム組成物の質を改善するための組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/815,599 | 2013-03-12 | ||
US13/815,599 US9381183B2 (en) | 2012-07-18 | 2013-03-12 | Methods for improving the quality of the meibum composition of meibomian glands |
PCT/US2014/014937 WO2014158356A1 (en) | 2013-03-12 | 2014-02-05 | Nutritional supplement targeting meibomian glands |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019011316A Division JP2019058194A (ja) | 2013-03-12 | 2019-01-25 | マイボーム腺を標的とする組成物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2016512245A JP2016512245A (ja) | 2016-04-25 |
JP2016512245A5 true JP2016512245A5 (ja) | 2017-03-09 |
JP6538022B2 JP6538022B2 (ja) | 2019-07-03 |
Family
ID=49947054
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016500204A Active JP6538022B2 (ja) | 2013-03-12 | 2014-02-05 | マイボーム腺を標的とする組成物 |
JP2019011316A Withdrawn JP2019058194A (ja) | 2013-03-12 | 2019-01-25 | マイボーム腺を標的とする組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019011316A Withdrawn JP2019058194A (ja) | 2013-03-12 | 2019-01-25 | マイボーム腺を標的とする組成物 |
Country Status (10)
Country | Link |
---|---|
US (1) | US9381183B2 (ja) |
EP (1) | EP2968243B1 (ja) |
JP (2) | JP6538022B2 (ja) |
KR (1) | KR101904850B1 (ja) |
CN (1) | CN105358142A (ja) |
CA (1) | CA2904737C (ja) |
CL (1) | CL2015002713A1 (ja) |
ES (1) | ES2743614T3 (ja) |
PE (1) | PE20160123A1 (ja) |
WO (1) | WO2014158356A1 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070060988A1 (en) | 2005-07-18 | 2007-03-15 | Grenon Stephen M | Melting meibomian gland obstructions |
US20090043365A1 (en) | 2005-07-18 | 2009-02-12 | Kolis Scientific, Inc. | Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma |
US20080114423A1 (en) | 2006-05-15 | 2008-05-15 | Grenon Stephen M | Apparatus for inner eyelid treatment of meibomian gland dysfunction |
US20070016256A1 (en) | 2005-07-18 | 2007-01-18 | Korb Donald R | Method and apparatus for treating gland dysfunction |
WO2013003594A2 (en) | 2011-06-28 | 2013-01-03 | Tearscience, Inc. | Methods and systems for treating meibomian gland dysfunction using radio-frequency energy |
US8950405B2 (en) | 2006-05-15 | 2015-02-10 | Tearscience, Inc. | Treatment of obstructive disorders of the eye or eyelid |
US7981145B2 (en) | 2005-07-18 | 2011-07-19 | Tearscience Inc. | Treatment of meibomian glands |
US9314369B2 (en) | 2006-05-15 | 2016-04-19 | Tearscience, Inc. | System for inner eyelid treatment of meibomian gland dysfunction |
US9115078B2 (en) * | 2011-07-18 | 2015-08-25 | Physicians Recommended Nutriceuticals, Llc | Compositions for improving the quality of the meibum composition of inflamed or dysfunctional meibomian glands |
US20210121430A1 (en) | 2011-07-18 | 2021-04-29 | Prn Physician Recommended Nutriceuticals, Llc | Omega-3 fatty acid supplementation for use in treating dry eye |
US10709680B2 (en) * | 2011-07-18 | 2020-07-14 | Physicians Recommended Nutriceuticals, Llc | Methods for treating dry eye |
DK2755647T3 (en) | 2011-09-12 | 2015-10-12 | Tassos Georgiou | Use of omega fatty acid for medical care |
JP6324671B2 (ja) * | 2012-06-19 | 2018-05-16 | 参天製薬株式会社 | ヘアレス動物の眼瞼状態の変化方法 |
US10842670B2 (en) | 2012-08-22 | 2020-11-24 | Johnson & Johnson Vision Care, Inc. | Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices |
WO2014208709A1 (ja) * | 2013-06-28 | 2014-12-31 | 学校法人 慶應義塾 | マイボーム腺機能不全の処置剤 |
CA2951162C (en) * | 2014-06-04 | 2019-04-23 | Tersus Pharmaceuticals, LLC | Methods of treating chronic dry eye disease using c16:1n7-palmitoleate and derivatives thereof |
WO2018005685A1 (en) * | 2016-06-29 | 2018-01-04 | Physicians Recommended Nutriceuticals, Llc | Compositions and methods for using same for reducing levels of arachidonic acid in tissue having undergone an invasive procedure |
CN108042522A (zh) * | 2017-12-29 | 2018-05-18 | 广东海洋大学 | 一种用于提高抗炎症功能的不饱和脂肪酸组合物及其应用 |
EP4093372B1 (en) * | 2020-01-23 | 2024-04-03 | Visufarma S.p.A. | Ophthalmic composition for the treatment of dry eye disease |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI225398B (en) | 1999-07-14 | 2004-12-21 | R Tech Ueno Ltd | Composition for treatment of external secretion disorders |
EP1228032B1 (en) | 1999-11-09 | 2004-08-04 | Alcon Inc. | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
US6506412B2 (en) | 2000-11-29 | 2003-01-14 | Sciencebased Health | Treatment of dry eye syndrome |
US20060127505A1 (en) | 2002-01-16 | 2006-06-15 | David Haines | Anti-inflammatory formulations |
US20040076695A1 (en) | 2002-07-08 | 2004-04-22 | Advanced Vision Research | EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
US6649195B1 (en) | 2002-07-11 | 2003-11-18 | Vitacost.Com, Inc. | Eyesight enhanced maintenance composition |
US7041840B2 (en) | 2002-12-18 | 2006-05-09 | Alberta Research Council Inc. | Antioxidant triacylglycerols and lipid compositions |
US9192586B2 (en) | 2003-03-10 | 2015-11-24 | Zeavision Llc | Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders |
US20070265341A1 (en) * | 2004-07-01 | 2007-11-15 | The Schepens Eye Research Institute Inc. | Compositions and methods for treating eye disorders and conditions |
JP2008505177A (ja) * | 2004-07-01 | 2008-02-21 | ザ・シェペンズ・アイ・リサーチ・インスティテュート・インコーポレーテッド | 目の障害および状態を治療するための組成物および方法 |
US8541413B2 (en) | 2004-10-01 | 2013-09-24 | Ramscor, Inc. | Sustained release eye drop formulations |
DE202004015931U1 (de) | 2004-10-13 | 2005-01-05 | Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh | Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung |
CN101330840A (zh) | 2005-12-20 | 2008-12-24 | 爱尔康研究有限公司 | 用于抑制黄斑变性进展和促进健康视觉的组合物和方法 |
US20100048705A1 (en) | 2006-11-09 | 2010-02-25 | Children's Medical Center Corporation | Methods of treating and preventing neovascularization with omega-3 polyunsaturated fatty acids |
EP1932520A1 (en) | 2006-12-15 | 2008-06-18 | Novartis AG | Nutritional supplement composition for treatment of ocular diseases |
EP1932521A1 (en) | 2006-12-15 | 2008-06-18 | Novartis AG | Nutritional supplement composition for treatment of ocular diseases |
US20090226547A1 (en) | 2008-03-05 | 2009-09-10 | Gilbard Jeffrey P | Dietary Supplement For Eye Health |
WO2010040232A1 (en) | 2008-10-09 | 2010-04-15 | Waratah Pharmaceuticals Inc. | Use of scyllo-inositols for the treatment of macular degeneration-related disorders |
IT1393419B1 (it) * | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
US20130011469A1 (en) | 2009-07-23 | 2013-01-10 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Krill oil and carotenoid composition, associated method and delivery system |
AU2010314956A1 (en) | 2009-11-06 | 2012-04-12 | Alcon Research, Ltd. | Nutritional supplements for relief of dry eye |
AU2011203832A1 (en) * | 2010-01-11 | 2012-08-23 | Gtx, Inc. | Methods of treating Meibomian gland dysfunction |
WO2012067224A1 (ja) * | 2010-11-19 | 2012-05-24 | 日本水産株式会社 | 角膜上皮障害及び/又は結膜上皮障害の治療又は予防剤 |
CA2738357C (en) | 2011-04-07 | 2019-08-06 | Amerisciences, Lp | Methods and compositions to promote ocular health |
-
2013
- 2013-03-12 US US13/815,599 patent/US9381183B2/en active Active
-
2014
- 2014-02-05 JP JP2016500204A patent/JP6538022B2/ja active Active
- 2014-02-05 CN CN201480027112.4A patent/CN105358142A/zh active Pending
- 2014-02-05 EP EP14773402.4A patent/EP2968243B1/en active Active
- 2014-02-05 ES ES14773402T patent/ES2743614T3/es active Active
- 2014-02-05 WO PCT/US2014/014937 patent/WO2014158356A1/en active Application Filing
- 2014-02-05 PE PE2015001987A patent/PE20160123A1/es unknown
- 2014-02-05 KR KR1020157027914A patent/KR101904850B1/ko active IP Right Grant
- 2014-02-05 CA CA2904737A patent/CA2904737C/en active Active
-
2015
- 2015-09-14 CL CL2015002713A patent/CL2015002713A1/es unknown
-
2019
- 2019-01-25 JP JP2019011316A patent/JP2019058194A/ja not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2016512245A5 (ja) | マイボーム腺を標的とする組成物 | |
PE20170431A1 (es) | Lipido que comprende acido docosapentaenoico | |
MY189576A (en) | Omega-3 fatty acid ester compositions | |
RU2014138996A (ru) | Гормонсодержащая эмульсия | |
NZ600167A (en) | Concentrated therapeutic phospholipid compositions | |
NZ626699A (en) | Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form | |
EA201400152A1 (ru) | Микроорганизмы, продуцирующие эйкозапентаеновую кислоту, композиции, содержащие жирные кислоты, и способы их получения и применения | |
CL2015002713A1 (es) | Métodos para mejorar la calidad de la composición del meibo de las glándulas de meibomio. | |
RU2018136872A (ru) | Композиции, содержащие 15-oh эпк, и способы их применения | |
HRP20171431T1 (hr) | Terapijska parenteralna primjena krilovog ulja | |
MX2016006094A (es) | Eliminacion de componentes de propanol indeseables. | |
WO2011097273A8 (en) | Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl l-cysteine | |
JP2015143248A5 (ja) | ||
WO2016027216A3 (en) | A synergistic edible oil composition | |
HRP20191963T1 (hr) | Smjesa masnih kiselina za primjenu u liječenju upalnih patologija | |
RU2013148780A (ru) | sn-1(3)МОНОАЦИЛГЛИЦЕРИДЫ И ПОГЛОЩЕНИЕ ЛИПИДОВ | |
JP2014505702A5 (ja) | ||
WO2016040570A3 (en) | Dietary emulsion formulations and methods for using the same | |
HRP20201221T1 (hr) | Sastavi omega 3 masnih kiselina za liječenje bolesti koje uključuju štete nastale u živčanom sustavu | |
WO2014165190A3 (en) | Compositions comprising docosapentaenoic acid and methods of use | |
JP2016501249A5 (ja) | ||
RU2016116835A (ru) | Способы и композиции для улучшения функции почек | |
JP2016501248A5 (ja) | ||
MY177028A (en) | Solid compositions of triglycerides and uses thereof | |
MX2015007085A (es) | Composiciones de acido omega-3 pentanoico y metodos de uso. |